Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:ccnd2 positive'
(id=12505528 ; fe=en:ccnd2 positive ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=5529 creation date=2019-04-28 touchdate=2025-07-16 16:19:47.000)
≈ 272 relations sortantes

  1. en:ccnd2 positive -- r_associated #0: 43 / 1 -> en:wnt family gene alteration positive
    n1=en:ccnd2 positive | n2=en:wnt family gene alteration positive | rel=r_associated | relid=0 | w=43
  2. en:ccnd2 positive -- r_associated #0: 42 / 0.977 -> en:igf1 positive
    n1=en:ccnd2 positive | n2=en:igf1 positive | rel=r_associated | relid=0 | w=42
  3. en:ccnd2 positive -- r_associated #0: 40 / 0.93 -> en:col6a3 positive
    n1=en:ccnd2 positive | n2=en:col6a3 positive | rel=r_associated | relid=0 | w=40
  4. en:ccnd2 positive -- r_associated #0: 40 / 0.93 -> en:somatostatin receptor positive
    n1=en:ccnd2 positive | n2=en:somatostatin receptor positive | rel=r_associated | relid=0 | w=40
  5. en:ccnd2 positive -- r_associated #0: 39 / 0.907 -> en:66 kda phosphoprotein antibody positive
    n1=en:ccnd2 positive | n2=en:66 kda phosphoprotein antibody positive | rel=r_associated | relid=0 | w=39
  6. en:ccnd2 positive -- r_associated #0: 39 / 0.907 -> en:cd44 positive
    n1=en:ccnd2 positive | n2=en:cd44 positive | rel=r_associated | relid=0 | w=39
  7. en:ccnd2 positive -- r_associated #0: 38 / 0.884 -> en:brca2 polymorphism positive
    n1=en:ccnd2 positive | n2=en:brca2 polymorphism positive | rel=r_associated | relid=0 | w=38
  8. en:ccnd2 positive -- r_associated #0: 38 / 0.884 -> en:kras positive
    n1=en:ccnd2 positive | n2=en:kras positive | rel=r_associated | relid=0 | w=38
  9. en:ccnd2 positive -- r_associated #0: 37 / 0.86 -> en:anti-poliovirus antibody positive
    n1=en:ccnd2 positive | n2=en:anti-poliovirus antibody positive | rel=r_associated | relid=0 | w=37
  10. en:ccnd2 positive -- r_associated #0: 37 / 0.86 -> en:gpc3 positive
    n1=en:ccnd2 positive | n2=en:gpc3 positive | rel=r_associated | relid=0 | w=37
  11. en:ccnd2 positive -- r_associated #0: 37 / 0.86 -> en:ha-1(h) genotype positive
    n1=en:ccnd2 positive | n2=en:ha-1(h) genotype positive | rel=r_associated | relid=0 | w=37
  12. en:ccnd2 positive -- r_associated #0: 37 / 0.86 -> en:hla-a1 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-a1 positive cells present | rel=r_associated | relid=0 | w=37
  13. en:ccnd2 positive -- r_associated #0: 37 / 0.86 -> en:ssx2 positive
    n1=en:ccnd2 positive | n2=en:ssx2 positive | rel=r_associated | relid=0 | w=37
  14. en:ccnd2 positive -- r_associated #0: 36 / 0.837 -> en:cd20 positive
    n1=en:ccnd2 positive | n2=en:cd20 positive | rel=r_associated | relid=0 | w=36
  15. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:alk fusion positive
    n1=en:ccnd2 positive | n2=en:alk fusion positive | rel=r_associated | relid=0 | w=35
  16. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:anti-nuclear factor positive
    n1=en:ccnd2 positive | n2=en:anti-nuclear factor positive | rel=r_associated | relid=0 | w=35
  17. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:ccnd1 positive
    n1=en:ccnd2 positive | n2=en:ccnd1 positive | rel=r_associated | relid=0 | w=35
  18. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:ccnd1 splice variant positive
    n1=en:ccnd2 positive | n2=en:ccnd1 splice variant positive | rel=r_associated | relid=0 | w=35
  19. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:cd7 positive
    n1=en:ccnd2 positive | n2=en:cd7 positive | rel=r_associated | relid=0 | w=35
  20. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:chromogranin positive
    n1=en:ccnd2 positive | n2=en:chromogranin positive | rel=r_associated | relid=0 | w=35
  21. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:enpp3 positive
    n1=en:ccnd2 positive | n2=en:enpp3 positive | rel=r_associated | relid=0 | w=35
  22. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:epstein-barr virus dna positive
    n1=en:ccnd2 positive | n2=en:epstein-barr virus dna positive | rel=r_associated | relid=0 | w=35
  23. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:fgfr2iiib positive
    n1=en:ccnd2 positive | n2=en:fgfr2iiib positive | rel=r_associated | relid=0 | w=35
  24. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:gnrhr positive
    n1=en:ccnd2 positive | n2=en:gnrhr positive | rel=r_associated | relid=0 | w=35
  25. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:hla-b*1501 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-b*1501 positive cells present | rel=r_associated | relid=0 | w=35
  26. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:human papillomavirus positive
    n1=en:ccnd2 positive | n2=en:human papillomavirus positive | rel=r_associated | relid=0 | w=35
  27. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:muc16 positive
    n1=en:ccnd2 positive | n2=en:muc16 positive | rel=r_associated | relid=0 | w=35
  28. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:phosphorylated signal transducer and activator of transcription 3 positive
    n1=en:ccnd2 positive | n2=en:phosphorylated signal transducer and activator of transcription 3 positive | rel=r_associated | relid=0 | w=35
  29. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:positive herpes simplex virus culture
    n1=en:ccnd2 positive | n2=en:positive herpes simplex virus culture | rel=r_associated | relid=0 | w=35
  30. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:ptprc positive
    n1=en:ccnd2 positive | n2=en:ptprc positive | rel=r_associated | relid=0 | w=35
  31. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:rara positive
    n1=en:ccnd2 positive | n2=en:rara positive | rel=r_associated | relid=0 | w=35
  32. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:ror1 positive
    n1=en:ccnd2 positive | n2=en:ror1 positive | rel=r_associated | relid=0 | w=35
  33. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:ros1 positive
    n1=en:ccnd2 positive | n2=en:ros1 positive | rel=r_associated | relid=0 | w=35
  34. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:rspo gene fusion positive
    n1=en:ccnd2 positive | n2=en:rspo gene fusion positive | rel=r_associated | relid=0 | w=35
  35. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:slc39a6 positive
    n1=en:ccnd2 positive | n2=en:slc39a6 positive | rel=r_associated | relid=0 | w=35
  36. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:slco1b3 gene positive
    n1=en:ccnd2 positive | n2=en:slco1b3 gene positive | rel=r_associated | relid=0 | w=35
  37. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:survivin positive
    n1=en:ccnd2 positive | n2=en:survivin positive | rel=r_associated | relid=0 | w=35
  38. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:tfe3 positive
    n1=en:ccnd2 positive | n2=en:tfe3 positive | rel=r_associated | relid=0 | w=35
  39. en:ccnd2 positive -- r_associated #0: 35 / 0.814 -> en:trk receptor family alteration positive
    n1=en:ccnd2 positive | n2=en:trk receptor family alteration positive | rel=r_associated | relid=0 | w=35
  40. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:ag7 antigen positive
    n1=en:ccnd2 positive | n2=en:ag7 antigen positive | rel=r_associated | relid=0 | w=34
  41. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:akt2 gene alteration positive
    n1=en:ccnd2 positive | n2=en:akt2 gene alteration positive | rel=r_associated | relid=0 | w=34
  42. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:akt3 gene alteration positive
    n1=en:ccnd2 positive | n2=en:akt3 gene alteration positive | rel=r_associated | relid=0 | w=34
  43. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:bcl6 positive
    n1=en:ccnd2 positive | n2=en:bcl6 positive | rel=r_associated | relid=0 | w=34
  44. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:bence jones protein present
    n1=en:ccnd2 positive | n2=en:bence jones protein present | rel=r_associated | relid=0 | w=34
  45. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:bst2 positive
    n1=en:ccnd2 positive | n2=en:bst2 positive | rel=r_associated | relid=0 | w=34
  46. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:ccnd3 positive
    n1=en:ccnd2 positive | n2=en:ccnd3 positive | rel=r_associated | relid=0 | w=34
  47. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:cd276 antigen positive
    n1=en:ccnd2 positive | n2=en:cd276 antigen positive | rel=r_associated | relid=0 | w=34
  48. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:coombs test positive
    n1=en:ccnd2 positive | n2=en:coombs test positive | rel=r_associated | relid=0 | w=34
  49. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:crlf2 positive
    n1=en:ccnd2 positive | n2=en:crlf2 positive | rel=r_associated | relid=0 | w=34
  50. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:fgf family alteration positive
    n1=en:ccnd2 positive | n2=en:fgf family alteration positive | rel=r_associated | relid=0 | w=34
  51. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:foxo1 fusion positive
    n1=en:ccnd2 positive | n2=en:foxo1 fusion positive | rel=r_associated | relid=0 | w=34
  52. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:heregulin positive
    n1=en:ccnd2 positive | n2=en:heregulin positive | rel=r_associated | relid=0 | w=34
  53. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:human anti-chimeric antibody positive
    n1=en:ccnd2 positive | n2=en:human anti-chimeric antibody positive | rel=r_associated | relid=0 | w=34
  54. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:human immunodeficiency virus positive
    n1=en:ccnd2 positive | n2=en:human immunodeficiency virus positive | rel=r_associated | relid=0 | w=34
  55. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:il13ra2 positive
    n1=en:ccnd2 positive | n2=en:il13ra2 positive | rel=r_associated | relid=0 | w=34
  56. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:irak1 fusion positive
    n1=en:ccnd2 positive | n2=en:irak1 fusion positive | rel=r_associated | relid=0 | w=34
  57. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:kit positive
    n1=en:ccnd2 positive | n2=en:kit positive | rel=r_associated | relid=0 | w=34
  58. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:magea6 positive
    n1=en:ccnd2 positive | n2=en:magea6 positive | rel=r_associated | relid=0 | w=34
  59. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:magec1 positive
    n1=en:ccnd2 positive | n2=en:magec1 positive | rel=r_associated | relid=0 | w=34
  60. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:monoclonal cellular population present
    n1=en:ccnd2 positive | n2=en:monoclonal cellular population present | rel=r_associated | relid=0 | w=34
  61. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:pdgfra gene fusion positive
    n1=en:ccnd2 positive | n2=en:pdgfra gene fusion positive | rel=r_associated | relid=0 | w=34
  62. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:pten positive
    n1=en:ccnd2 positive | n2=en:pten positive | rel=r_associated | relid=0 | w=34
  63. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:rela fusion positive
    n1=en:ccnd2 positive | n2=en:rela fusion positive | rel=r_associated | relid=0 | w=34
  64. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:ropn1 positive
    n1=en:ccnd2 positive | n2=en:ropn1 positive | rel=r_associated | relid=0 | w=34
  65. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:runx1/runx1t1 fusion positive
    n1=en:ccnd2 positive | n2=en:runx1/runx1t1 fusion positive | rel=r_associated | relid=0 | w=34
  66. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:spn positive
    n1=en:ccnd2 positive | n2=en:spn positive | rel=r_associated | relid=0 | w=34
  67. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:thbs1 overexpression positive
    n1=en:ccnd2 positive | n2=en:thbs1 overexpression positive | rel=r_associated | relid=0 | w=34
  68. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:tp53 gene alteration positive
    n1=en:ccnd2 positive | n2=en:tp53 gene alteration positive | rel=r_associated | relid=0 | w=34
  69. en:ccnd2 positive -- r_associated #0: 34 / 0.791 -> en:wnt positive
    n1=en:ccnd2 positive | n2=en:wnt positive | rel=r_associated | relid=0 | w=34
  70. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:bcl2 positive
    n1=en:ccnd2 positive | n2=en:bcl2 positive | rel=r_associated | relid=0 | w=32
  71. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:bk virus positive
    n1=en:ccnd2 positive | n2=en:bk virus positive | rel=r_associated | relid=0 | w=32
  72. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:cd4 positive
    n1=en:ccnd2 positive | n2=en:cd4 positive | rel=r_associated | relid=0 | w=32
  73. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:cd5 positive
    n1=en:ccnd2 positive | n2=en:cd5 positive | rel=r_associated | relid=0 | w=32
  74. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:cd79b positive
    n1=en:ccnd2 positive | n2=en:cd79b positive | rel=r_associated | relid=0 | w=32
  75. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:circulating tumor cells positive
    n1=en:ccnd2 positive | n2=en:circulating tumor cells positive | rel=r_associated | relid=0 | w=32
  76. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:cldn18.2 positive
    n1=en:ccnd2 positive | n2=en:cldn18.2 positive | rel=r_associated | relid=0 | w=32
  77. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:clostridium difficile positive
    n1=en:ccnd2 positive | n2=en:clostridium difficile positive | rel=r_associated | relid=0 | w=32
  78. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:clostridium difficile toxin positive
    n1=en:ccnd2 positive | n2=en:clostridium difficile toxin positive | rel=r_associated | relid=0 | w=32
  79. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:egfr positive
    n1=en:ccnd2 positive | n2=en:egfr positive | rel=r_associated | relid=0 | w=32
  80. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:erbb3 positive
    n1=en:ccnd2 positive | n2=en:erbb3 positive | rel=r_associated | relid=0 | w=32
  81. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:gpnmb positive
    n1=en:ccnd2 positive | n2=en:gpnmb positive | rel=r_associated | relid=0 | w=32
  82. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:hla-a3/a11 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-a3/a11 positive cells present | rel=r_associated | relid=0 | w=32
  83. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:human herpesvirus 1 positive
    n1=en:ccnd2 positive | n2=en:human herpesvirus 1 positive | rel=r_associated | relid=0 | w=32
  84. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:merkel cell polyomavirus t antigen positive
    n1=en:ccnd2 positive | n2=en:merkel cell polyomavirus t antigen positive | rel=r_associated | relid=0 | w=32
  85. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:muc1 positive
    n1=en:ccnd2 positive | n2=en:muc1 positive | rel=r_associated | relid=0 | w=32
  86. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:ncam1 positive
    n1=en:ccnd2 positive | n2=en:ncam1 positive | rel=r_associated | relid=0 | w=32
  87. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:pdgfa gene fusion positive
    n1=en:ccnd2 positive | n2=en:pdgfa gene fusion positive | rel=r_associated | relid=0 | w=32
  88. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:pdgfb gene fusion positive
    n1=en:ccnd2 positive | n2=en:pdgfb gene fusion positive | rel=r_associated | relid=0 | w=32
  89. en:ccnd2 positive -- r_associated #0: 32 / 0.744 -> en:slc6a8 positive
    n1=en:ccnd2 positive | n2=en:slc6a8 positive | rel=r_associated | relid=0 | w=32
  90. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:akap4 positive
    n1=en:ccnd2 positive | n2=en:akap4 positive | rel=r_associated | relid=0 | w=31
  91. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:alk positive
    n1=en:ccnd2 positive | n2=en:alk positive | rel=r_associated | relid=0 | w=31
  92. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:alkati positive
    n1=en:ccnd2 positive | n2=en:alkati positive | rel=r_associated | relid=0 | w=31
  93. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:arid1a positive
    n1=en:ccnd2 positive | n2=en:arid1a positive | rel=r_associated | relid=0 | w=31
  94. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:cd38 positive
    n1=en:ccnd2 positive | n2=en:cd38 positive | rel=r_associated | relid=0 | w=31
  95. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:cd8 positive
    n1=en:ccnd2 positive | n2=en:cd8 positive | rel=r_associated | relid=0 | w=31
  96. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:ctrp molecular genetic biomarker terminology
    n1=en:ccnd2 positive | n2=en:ctrp molecular genetic biomarker terminology | rel=r_associated | relid=0 | w=31
  97. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:disseminated tumor cells positive
    n1=en:ccnd2 positive | n2=en:disseminated tumor cells positive | rel=r_associated | relid=0 | w=31
  98. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:epor fusion positive
    n1=en:ccnd2 positive | n2=en:epor fusion positive | rel=r_associated | relid=0 | w=31
  99. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:epstein-barr virus antibody positive
    n1=en:ccnd2 positive | n2=en:epstein-barr virus antibody positive | rel=r_associated | relid=0 | w=31
  100. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:estrogen receptor and/or progesterone receptor positive
    n1=en:ccnd2 positive | n2=en:estrogen receptor and/or progesterone receptor positive | rel=r_associated | relid=0 | w=31
  101. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:fgf19 positive
    n1=en:ccnd2 positive | n2=en:fgf19 positive | rel=r_associated | relid=0 | w=31
  102. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:her2/neu positive
    n1=en:ccnd2 positive | n2=en:her2/neu positive | rel=r_associated | relid=0 | w=31
  103. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:hla phenotype positive
    n1=en:ccnd2 positive | n2=en:hla phenotype positive | rel=r_associated | relid=0 | w=31
  104. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:hla-a2 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-a2 positive cells present | rel=r_associated | relid=0 | w=31
  105. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:hla-a24 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-a24 positive cells present | rel=r_associated | relid=0 | w=31
  106. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:hla-a3 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-a3 positive cells present | rel=r_associated | relid=0 | w=31
  107. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:hoxa9 positive
    n1=en:ccnd2 positive | n2=en:hoxa9 positive | rel=r_associated | relid=0 | w=31
  108. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:human herpesvirus 6 positive
    n1=en:ccnd2 positive | n2=en:human herpesvirus 6 positive | rel=r_associated | relid=0 | w=31
  109. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:il2rb positive
    n1=en:ccnd2 positive | n2=en:il2rb positive | rel=r_associated | relid=0 | w=31
  110. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:kir2dl1 polymorphism positive
    n1=en:ccnd2 positive | n2=en:kir2dl1 polymorphism positive | rel=r_associated | relid=0 | w=31
  111. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:magea10 positive
    n1=en:ccnd2 positive | n2=en:magea10 positive | rel=r_associated | relid=0 | w=31
  112. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:magea3 positive
    n1=en:ccnd2 positive | n2=en:magea3 positive | rel=r_associated | relid=0 | w=31
  113. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:met overexpression positive
    n1=en:ccnd2 positive | n2=en:met overexpression positive | rel=r_associated | relid=0 | w=31
  114. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:myc positive
    n1=en:ccnd2 positive | n2=en:myc positive | rel=r_associated | relid=0 | w=31
  115. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:nr3c1 positive
    n1=en:ccnd2 positive | n2=en:nr3c1 positive | rel=r_associated | relid=0 | w=31
  116. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:ret positive
    n1=en:ccnd2 positive | n2=en:ret positive | rel=r_associated | relid=0 | w=31
  117. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:slc5a5 positive
    n1=en:ccnd2 positive | n2=en:slc5a5 positive | rel=r_associated | relid=0 | w=31
  118. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:steap1 positive
    n1=en:ccnd2 positive | n2=en:steap1 positive | rel=r_associated | relid=0 | w=31
  119. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:tp53 overexpression positive
    n1=en:ccnd2 positive | n2=en:tp53 overexpression positive | rel=r_associated | relid=0 | w=31
  120. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:tumor-associated peptide antigens present
    n1=en:ccnd2 positive | n2=en:tumor-associated peptide antigens present | rel=r_associated | relid=0 | w=31
  121. en:ccnd2 positive -- r_associated #0: 31 / 0.721 -> en:tyk2 fusion positive
    n1=en:ccnd2 positive | n2=en:tyk2 fusion positive | rel=r_associated | relid=0 | w=31
  122. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:abcb4 positive
    n1=en:ccnd2 positive | n2=en:abcb4 positive | rel=r_associated | relid=0 | w=30
  123. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:abl positive
    n1=en:ccnd2 positive | n2=en:abl positive | rel=r_associated | relid=0 | w=30
  124. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:akt1 gene alteration positive
    n1=en:ccnd2 positive | n2=en:akt1 gene alteration positive | rel=r_associated | relid=0 | w=30
  125. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:androgen receptor positive
    n1=en:ccnd2 positive | n2=en:androgen receptor positive | rel=r_associated | relid=0 | w=30
  126. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:bcl6 overexpression positive
    n1=en:ccnd2 positive | n2=en:bcl6 overexpression positive | rel=r_associated | relid=0 | w=30
  127. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:braf fusion positive
    n1=en:ccnd2 positive | n2=en:braf fusion positive | rel=r_associated | relid=0 | w=30
  128. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:carcinoembryonic antigen positive
    n1=en:ccnd2 positive | n2=en:carcinoembryonic antigen positive | rel=r_associated | relid=0 | w=30
  129. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:cd86 positive
    n1=en:ccnd2 positive | n2=en:cd86 positive | rel=r_associated | relid=0 | w=30
  130. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:ctag1b positive
    n1=en:ccnd2 positive | n2=en:ctag1b positive | rel=r_associated | relid=0 | w=30
  131. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:ctrp biomarker terminology
    n1=en:ccnd2 positive | n2=en:ctrp biomarker terminology | rel=r_associated | relid=0 | w=30
  132. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:ctrp terminology
    n1=en:ccnd2 positive | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=30
  133. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:cytomegalovirus positive
    n1=en:ccnd2 positive | n2=en:cytomegalovirus positive | rel=r_associated | relid=0 | w=30
  134. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:epstein-barr virus positive
    n1=en:ccnd2 positive | n2=en:epstein-barr virus positive | rel=r_associated | relid=0 | w=30
  135. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:hepatitis b virus core antibody positive
    n1=en:ccnd2 positive | n2=en:hepatitis b virus core antibody positive | rel=r_associated | relid=0 | w=30
  136. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:hepatitis b virus positive
    n1=en:ccnd2 positive | n2=en:hepatitis b virus positive | rel=r_associated | relid=0 | w=30
  137. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:hif1a overexpression positive
    n1=en:ccnd2 positive | n2=en:hif1a overexpression positive | rel=r_associated | relid=0 | w=30
  138. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:hla-a11 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-a11 positive cells present | rel=r_associated | relid=0 | w=30
  139. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:hla-cw*0702 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-cw*0702 positive cells present | rel=r_associated | relid=0 | w=30
  140. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:hormone receptor/her2 positive
    n1=en:ccnd2 positive | n2=en:hormone receptor/her2 positive | rel=r_associated | relid=0 | w=30
  141. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:htlv-1 positive
    n1=en:ccnd2 positive | n2=en:htlv-1 positive | rel=r_associated | relid=0 | w=30
  142. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:igf1r positive
    n1=en:ccnd2 positive | n2=en:igf1r positive | rel=r_associated | relid=0 | w=30
  143. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:jak3 fusion positive
    n1=en:ccnd2 positive | n2=en:jak3 fusion positive | rel=r_associated | relid=0 | w=30
  144. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:lypd3 positive
    n1=en:ccnd2 positive | n2=en:lypd3 positive | rel=r_associated | relid=0 | w=30
  145. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:mapk gene alteration positive
    n1=en:ccnd2 positive | n2=en:mapk gene alteration positive | rel=r_associated | relid=0 | w=30
  146. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:mesothelin positive
    n1=en:ccnd2 positive | n2=en:mesothelin positive | rel=r_associated | relid=0 | w=30
  147. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:mki67 positive
    n1=en:ccnd2 positive | n2=en:mki67 positive | rel=r_associated | relid=0 | w=30
  148. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:mll positive
    n1=en:ccnd2 positive | n2=en:mll positive | rel=r_associated | relid=0 | w=30
  149. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:nos2 positive
    n1=en:ccnd2 positive | n2=en:nos2 positive | rel=r_associated | relid=0 | w=30
  150. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:pmel positive
    n1=en:ccnd2 positive | n2=en:pmel positive | rel=r_associated | relid=0 | w=30
  151. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:pml/rara fusion positive
    n1=en:ccnd2 positive | n2=en:pml/rara fusion positive | rel=r_associated | relid=0 | w=30
  152. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:smarcb1 positive
    n1=en:ccnd2 positive | n2=en:smarcb1 positive | rel=r_associated | relid=0 | w=30
  153. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:t(15;17) positive
    n1=en:ccnd2 positive | n2=en:t(15;17) positive | rel=r_associated | relid=0 | w=30
  154. en:ccnd2 positive -- r_associated #0: 30 / 0.698 -> en:tyrosinase positive
    n1=en:ccnd2 positive | n2=en:tyrosinase positive | rel=r_associated | relid=0 | w=30
  155. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:adenovirus positive
    n1=en:ccnd2 positive | n2=en:adenovirus positive | rel=r_associated | relid=0 | w=29
  156. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:bap1 loss of function mutation positive
    n1=en:ccnd2 positive | n2=en:bap1 loss of function mutation positive | rel=r_associated | relid=0 | w=29
  157. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:biomarker positive malignant neoplasm
    n1=en:ccnd2 positive | n2=en:biomarker positive malignant neoplasm | rel=r_associated | relid=0 | w=29
  158. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:c3d positive
    n1=en:ccnd2 positive | n2=en:c3d positive | rel=r_associated | relid=0 | w=29
  159. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:cd28 positive
    n1=en:ccnd2 positive | n2=en:cd28 positive | rel=r_associated | relid=0 | w=29
  160. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:cd70 positive
    n1=en:ccnd2 positive | n2=en:cd70 positive | rel=r_associated | relid=0 | w=29
  161. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:ctnnb1 positive
    n1=en:ccnd2 positive | n2=en:ctnnb1 positive | rel=r_associated | relid=0 | w=29
  162. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:egfr gene alteration positive
    n1=en:ccnd2 positive | n2=en:egfr gene alteration positive | rel=r_associated | relid=0 | w=29
  163. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:fcer2 positive
    n1=en:ccnd2 positive | n2=en:fcer2 positive | rel=r_associated | relid=0 | w=29
  164. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:hla-a*0201 ha-1 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-a*0201 ha-1 positive cells present | rel=r_associated | relid=0 | w=29
  165. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:hoxa10 positive
    n1=en:ccnd2 positive | n2=en:hoxa10 positive | rel=r_associated | relid=0 | w=29
  166. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:human anti-mouse antibodies positive
    n1=en:ccnd2 positive | n2=en:human anti-mouse antibodies positive | rel=r_associated | relid=0 | w=29
  167. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:ighv4-34 positive
    n1=en:ccnd2 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=29
  168. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:interleukin-3 receptor subunit alpha positive
    n1=en:ccnd2 positive | n2=en:interleukin-3 receptor subunit alpha positive | rel=r_associated | relid=0 | w=29
  169. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:jak2 fusion positive
    n1=en:ccnd2 positive | n2=en:jak2 fusion positive | rel=r_associated | relid=0 | w=29
  170. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:latent membrane protein 1 positive
    n1=en:ccnd2 positive | n2=en:latent membrane protein 1 positive | rel=r_associated | relid=0 | w=29
  171. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:magea4 positive
    n1=en:ccnd2 positive | n2=en:magea4 positive | rel=r_associated | relid=0 | w=29
  172. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:mlana positive
    n1=en:ccnd2 positive | n2=en:mlana positive | rel=r_associated | relid=0 | w=29
  173. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:pdgfr positive
    n1=en:ccnd2 positive | n2=en:pdgfr positive | rel=r_associated | relid=0 | w=29
  174. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:positive lymph node
    n1=en:ccnd2 positive | n2=en:positive lymph node | rel=r_associated | relid=0 | w=29
  175. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:prame positive
    n1=en:ccnd2 positive | n2=en:prame positive | rel=r_associated | relid=0 | w=29
  176. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:pten alteration positive
    n1=en:ccnd2 positive | n2=en:pten alteration positive | rel=r_associated | relid=0 | w=29
  177. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:rb1 positive
    n1=en:ccnd2 positive | n2=en:rb1 positive | rel=r_associated | relid=0 | w=29
  178. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:ros1 fusion positive
    n1=en:ccnd2 positive | n2=en:ros1 fusion positive | rel=r_associated | relid=0 | w=29
  179. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:s100b positive
    n1=en:ccnd2 positive | n2=en:s100b positive | rel=r_associated | relid=0 | w=29
  180. en:ccnd2 positive -- r_associated #0: 29 / 0.674 -> en:ugt1a1 polymorphism positive
    n1=en:ccnd2 positive | n2=en:ugt1a1 polymorphism positive | rel=r_associated | relid=0 | w=29
  181. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:ar-v7 positive
    n1=en:ccnd2 positive | n2=en:ar-v7 positive | rel=r_associated | relid=0 | w=28
  182. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:axl overexpression positive
    n1=en:ccnd2 positive | n2=en:axl overexpression positive | rel=r_associated | relid=0 | w=28
  183. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:brca1 polymorphism positive
    n1=en:ccnd2 positive | n2=en:brca1 polymorphism positive | rel=r_associated | relid=0 | w=28
  184. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:cd19 positive
    n1=en:ccnd2 positive | n2=en:cd19 positive | rel=r_associated | relid=0 | w=28
  185. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:cd3 positive
    n1=en:ccnd2 positive | n2=en:cd3 positive | rel=r_associated | relid=0 | w=28
  186. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:cd30 positive
    n1=en:ccnd2 positive | n2=en:cd30 positive | rel=r_associated | relid=0 | w=28
  187. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:cd33 positive
    n1=en:ccnd2 positive | n2=en:cd33 positive | rel=r_associated | relid=0 | w=28
  188. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:cd52 positive
    n1=en:ccnd2 positive | n2=en:cd52 positive | rel=r_associated | relid=0 | w=28
  189. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:ctla4 positive
    n1=en:ccnd2 positive | n2=en:ctla4 positive | rel=r_associated | relid=0 | w=28
  190. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:fgfr2 positive
    n1=en:ccnd2 positive | n2=en:fgfr2 positive | rel=r_associated | relid=0 | w=28
  191. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:hla-dpb1*04 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-dpb1*04 positive cells present | rel=r_associated | relid=0 | w=28
  192. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:il2ra positive
    n1=en:ccnd2 positive | n2=en:il2ra positive | rel=r_associated | relid=0 | w=28
  193. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:kdr positive
    n1=en:ccnd2 positive | n2=en:kdr positive | rel=r_associated | relid=0 | w=28
  194. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:kit overexpression positive
    n1=en:ccnd2 positive | n2=en:kit overexpression positive | rel=r_associated | relid=0 | w=28
  195. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:magea12 positive
    n1=en:ccnd2 positive | n2=en:magea12 positive | rel=r_associated | relid=0 | w=28
  196. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:mpo positive
    n1=en:ccnd2 positive | n2=en:mpo positive | rel=r_associated | relid=0 | w=28
  197. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:mycn positive
    n1=en:ccnd2 positive | n2=en:mycn positive | rel=r_associated | relid=0 | w=28
  198. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:myd88 fusion positive
    n1=en:ccnd2 positive | n2=en:myd88 fusion positive | rel=r_associated | relid=0 | w=28
  199. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:nf1 positive
    n1=en:ccnd2 positive | n2=en:nf1 positive | rel=r_associated | relid=0 | w=28
  200. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:pttg1 positive
    n1=en:ccnd2 positive | n2=en:pttg1 positive | rel=r_associated | relid=0 | w=28
  201. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:slc45a2 positive
    n1=en:ccnd2 positive | n2=en:slc45a2 positive | rel=r_associated | relid=0 | w=28
  202. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:t(11;14) positive
    n1=en:ccnd2 positive | n2=en:t(11;14) positive | rel=r_associated | relid=0 | w=28
  203. en:ccnd2 positive -- r_associated #0: 28 / 0.651 -> en:wt1 positive
    n1=en:ccnd2 positive | n2=en:wt1 positive | rel=r_associated | relid=0 | w=28
  204. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:alk gene alteration positive
    n1=en:ccnd2 positive | n2=en:alk gene alteration positive | rel=r_associated | relid=0 | w=27
  205. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:bcl2 overexpression positive
    n1=en:ccnd2 positive | n2=en:bcl2 overexpression positive | rel=r_associated | relid=0 | w=27
  206. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:ca19-9 antigen positive
    n1=en:ccnd2 positive | n2=en:ca19-9 antigen positive | rel=r_associated | relid=0 | w=27
  207. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:cd1a positive
    n1=en:ccnd2 positive | n2=en:cd1a positive | rel=r_associated | relid=0 | w=27
  208. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:cd22 positive
    n1=en:ccnd2 positive | n2=en:cd22 positive | rel=r_associated | relid=0 | w=27
  209. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:cd34 positive
    n1=en:ccnd2 positive | n2=en:cd34 positive | rel=r_associated | relid=0 | w=27
  210. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:cdh3 positive
    n1=en:ccnd2 positive | n2=en:cdh3 positive | rel=r_associated | relid=0 | w=27
  211. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:cox2 positive
    n1=en:ccnd2 positive | n2=en:cox2 positive | rel=r_associated | relid=0 | w=27
  212. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:ctrp disease terminology
    n1=en:ccnd2 positive | n2=en:ctrp disease terminology | rel=r_associated | relid=0 | w=27
  213. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:estrogen receptor positive
    n1=en:ccnd2 positive | n2=en:estrogen receptor positive | rel=r_associated | relid=0 | w=27
  214. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:f3 positive
    n1=en:ccnd2 positive | n2=en:f3 positive | rel=r_associated | relid=0 | w=27
  215. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:fgfr family alteration positive
    n1=en:ccnd2 positive | n2=en:fgfr family alteration positive | rel=r_associated | relid=0 | w=27
  216. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:fgfr1 positive
    n1=en:ccnd2 positive | n2=en:fgfr1 positive | rel=r_associated | relid=0 | w=27
  217. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:flt3 internal tandem duplication positive
    n1=en:ccnd2 positive | n2=en:flt3 internal tandem duplication positive | rel=r_associated | relid=0 | w=27
  218. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:folh1 positive
    n1=en:ccnd2 positive | n2=en:folh1 positive | rel=r_associated | relid=0 | w=27
  219. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:ganglioside gd2 positive
    n1=en:ccnd2 positive | n2=en:ganglioside gd2 positive | rel=r_associated | relid=0 | w=27
  220. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:hepatitis c virus positive
    n1=en:ccnd2 positive | n2=en:hepatitis c virus positive | rel=r_associated | relid=0 | w=27
  221. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:hla class i histocompatibility antigen, a-0201 alpha chain positive
    n1=en:ccnd2 positive | n2=en:hla class i histocompatibility antigen, a-0201 alpha chain positive | rel=r_associated | relid=0 | w=27
  222. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:hla-a31 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-a31 positive cells present | rel=r_associated | relid=0 | w=27
  223. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:htlv-1 antibody positive
    n1=en:ccnd2 positive | n2=en:htlv-1 antibody positive | rel=r_associated | relid=0 | w=27
  224. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:human herpesvirus 8 positive
    n1=en:ccnd2 positive | n2=en:human herpesvirus 8 positive | rel=r_associated | relid=0 | w=27
  225. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:isg15 positive
    n1=en:ccnd2 positive | n2=en:isg15 positive | rel=r_associated | relid=0 | w=27
  226. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:jc virus positive
    n1=en:ccnd2 positive | n2=en:jc virus positive | rel=r_associated | relid=0 | w=27
  227. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:met fusion gene positive
    n1=en:ccnd2 positive | n2=en:met fusion gene positive | rel=r_associated | relid=0 | w=27
  228. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:met positive
    n1=en:ccnd2 positive | n2=en:met positive | rel=r_associated | relid=0 | w=27
  229. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:muc16 ectodomain antigen positive
    n1=en:ccnd2 positive | n2=en:muc16 ectodomain antigen positive | rel=r_associated | relid=0 | w=27
  230. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:pdgfrb gene fusion positive
    n1=en:ccnd2 positive | n2=en:pdgfrb gene fusion positive | rel=r_associated | relid=0 | w=27
  231. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:pi3k alteration positive
    n1=en:ccnd2 positive | n2=en:pi3k alteration positive | rel=r_associated | relid=0 | w=27
  232. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:positive pseudomonas culture
    n1=en:ccnd2 positive | n2=en:positive pseudomonas culture | rel=r_associated | relid=0 | w=27
  233. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:prlr positive
    n1=en:ccnd2 positive | n2=en:prlr positive | rel=r_associated | relid=0 | w=27
  234. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:progesterone receptor positive
    n1=en:ccnd2 positive | n2=en:progesterone receptor positive | rel=r_associated | relid=0 | w=27
  235. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:rb1 gene alteration positive
    n1=en:ccnd2 positive | n2=en:rb1 gene alteration positive | rel=r_associated | relid=0 | w=27
  236. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:ros1 gene alteration positive
    n1=en:ccnd2 positive | n2=en:ros1 gene alteration positive | rel=r_associated | relid=0 | w=27
  237. en:ccnd2 positive -- r_associated #0: 27 / 0.628 -> en:rous sarcoma virus positive
    n1=en:ccnd2 positive | n2=en:rous sarcoma virus positive | rel=r_associated | relid=0 | w=27
  238. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:abcb11 positive
    n1=en:ccnd2 positive | n2=en:abcb11 positive | rel=r_associated | relid=0 | w=26
  239. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:ccnd2 gene
    n1=en:ccnd2 positive | n2=en:ccnd2 gene | rel=r_associated | relid=0 | w=26
  240. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:cd11c positive
    n1=en:ccnd2 positive | n2=en:cd11c positive | rel=r_associated | relid=0 | w=26
  241. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:cd2 positive
    n1=en:ccnd2 positive | n2=en:cd2 positive | rel=r_associated | relid=0 | w=26
  242. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:cd57 positive
    n1=en:ccnd2 positive | n2=en:cd57 positive | rel=r_associated | relid=0 | w=26
  243. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:cdkn2a-p16 positive
    n1=en:ccnd2 positive | n2=en:cdkn2a-p16 positive | rel=r_associated | relid=0 | w=26
  244. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:ctag2 positive
    n1=en:ccnd2 positive | n2=en:ctag2 positive | rel=r_associated | relid=0 | w=26
  245. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:dll3 positive
    n1=en:ccnd2 positive | n2=en:dll3 positive | rel=r_associated | relid=0 | w=26
  246. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:egfrviii positive
    n1=en:ccnd2 positive | n2=en:egfrviii positive | rel=r_associated | relid=0 | w=26
  247. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:epstein-barr virus early rna positive
    n1=en:ccnd2 positive | n2=en:epstein-barr virus early rna positive | rel=r_associated | relid=0 | w=26
  248. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:eso-1 positive cells present
    n1=en:ccnd2 positive | n2=en:eso-1 positive cells present | rel=r_associated | relid=0 | w=26
  249. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:flt3 positive
    n1=en:ccnd2 positive | n2=en:flt3 positive | rel=r_associated | relid=0 | w=26
  250. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:folate receptor family positive
    n1=en:ccnd2 positive | n2=en:folate receptor family positive | rel=r_associated | relid=0 | w=26
  251. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:gli1 positive
    n1=en:ccnd2 positive | n2=en:gli1 positive | rel=r_associated | relid=0 | w=26
  252. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:gucy2c positive
    n1=en:ccnd2 positive | n2=en:gucy2c positive | rel=r_associated | relid=0 | w=26
  253. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:hepatitis b surface antibody positive
    n1=en:ccnd2 positive | n2=en:hepatitis b surface antibody positive | rel=r_associated | relid=0 | w=26
  254. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:hla-a*26 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-a*26 positive cells present | rel=r_associated | relid=0 | w=26
  255. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:hla-b*4601 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-b*4601 positive cells present | rel=r_associated | relid=0 | w=26
  256. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:hla-b*5103 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-b*5103 positive cells present | rel=r_associated | relid=0 | w=26
  257. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:hla-c*0404 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-c*0404 positive cells present | rel=r_associated | relid=0 | w=26
  258. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:hla-dp4 positive cells present
    n1=en:ccnd2 positive | n2=en:hla-dp4 positive cells present | rel=r_associated | relid=0 | w=26
  259. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:mecom positive
    n1=en:ccnd2 positive | n2=en:mecom positive | rel=r_associated | relid=0 | w=26
  260. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:mitf positive
    n1=en:ccnd2 positive | n2=en:mitf positive | rel=r_associated | relid=0 | w=26
  261. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:nectin4 positive
    n1=en:ccnd2 positive | n2=en:nectin4 positive | rel=r_associated | relid=0 | w=26
  262. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:positive blood culture
    n1=en:ccnd2 positive | n2=en:positive blood culture | rel=r_associated | relid=0 | w=26
  263. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:positive surgical margin
    n1=en:ccnd2 positive | n2=en:positive surgical margin | rel=r_associated | relid=0 | w=26
  264. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:ret fusion positive
    n1=en:ccnd2 positive | n2=en:ret fusion positive | rel=r_associated | relid=0 | w=26
  265. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:scgb2a2 positive
    n1=en:ccnd2 positive | n2=en:scgb2a2 positive | rel=r_associated | relid=0 | w=26
  266. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:shh positive
    n1=en:ccnd2 positive | n2=en:shh positive | rel=r_associated | relid=0 | w=26
  267. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:spa17 positive
    n1=en:ccnd2 positive | n2=en:spa17 positive | rel=r_associated | relid=0 | w=26
  268. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:spanxb1 positive
    n1=en:ccnd2 positive | n2=en:spanxb1 positive | rel=r_associated | relid=0 | w=26
  269. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:tnfrsf17 positive
    n1=en:ccnd2 positive | n2=en:tnfrsf17 positive | rel=r_associated | relid=0 | w=26
  270. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:tp53 positive
    n1=en:ccnd2 positive | n2=en:tp53 positive | rel=r_associated | relid=0 | w=26
  271. en:ccnd2 positive -- r_associated #0: 26 / 0.605 -> en:vegf overexpression positive
    n1=en:ccnd2 positive | n2=en:vegf overexpression positive | rel=r_associated | relid=0 | w=26
  272. en:ccnd2 positive -- r_associated #0: 1 / 0.023 -> en:laboratory or test result
    n1=en:ccnd2 positive | n2=en:laboratory or test result | rel=r_associated | relid=0 | w=1
≈ 273 relations entrantes

  1. en:cox2 positive --- r_associated #0: 42 --> en:ccnd2 positive
    n1=en:cox2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=42
  2. en:ag7 antigen positive --- r_associated #0: 34 --> en:ccnd2 positive
    n1=en:ag7 antigen positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=34
  3. en:egfr positive --- r_associated #0: 30 --> en:ccnd2 positive
    n1=en:egfr positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=30
  4. en:cd38 positive --- r_associated #0: 29 --> en:ccnd2 positive
    n1=en:cd38 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=29
  5. en:egfr gene alteration positive --- r_associated #0: 28 --> en:ccnd2 positive
    n1=en:egfr gene alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=28
  6. en:66 kda phosphoprotein antibody positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:66 kda phosphoprotein antibody positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  7. en:abcb11 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:abcb11 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  8. en:abcb4 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:abcb4 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  9. en:abl positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:abl positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  10. en:adenovirus positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:adenovirus positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  11. en:akap4 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:akap4 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  12. en:akt1 gene alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:akt1 gene alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  13. en:akt2 gene alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:akt2 gene alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  14. en:akt3 gene alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:akt3 gene alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  15. en:alk fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:alk fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  16. en:alk gene alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:alk gene alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  17. en:alk positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:alk positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  18. en:alkati positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:alkati positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  19. en:androgen receptor positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:androgen receptor positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  20. en:anti-nuclear factor positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:anti-nuclear factor positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  21. en:anti-poliovirus antibody positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:anti-poliovirus antibody positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  22. en:ar-v7 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ar-v7 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  23. en:arid1a positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:arid1a positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  24. en:axl overexpression positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:axl overexpression positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  25. en:bap1 loss of function mutation positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:bap1 loss of function mutation positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  26. en:bcl2 overexpression positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:bcl2 overexpression positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  27. en:bcl2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:bcl2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  28. en:bcl6 overexpression positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:bcl6 overexpression positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  29. en:bcl6 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:bcl6 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  30. en:bence jones protein present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:bence jones protein present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  31. en:biomarker positive malignant neoplasm --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:biomarker positive malignant neoplasm | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  32. en:bk virus positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:bk virus positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  33. en:braf fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:braf fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  34. en:brca1 polymorphism positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:brca1 polymorphism positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  35. en:brca2 polymorphism positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:brca2 polymorphism positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  36. en:bst2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:bst2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  37. en:c3d positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:c3d positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  38. en:ca19-9 antigen positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ca19-9 antigen positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  39. en:carcinoembryonic antigen positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:carcinoembryonic antigen positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  40. en:ccnd1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ccnd1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  41. en:ccnd1 splice variant positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ccnd1 splice variant positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  42. en:ccnd2 gene --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ccnd2 gene | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  43. en:ccnd3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ccnd3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  44. en:cd11c positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd11c positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  45. en:cd19 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd19 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  46. en:cd1a positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd1a positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  47. en:cd2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  48. en:cd20 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd20 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  49. en:cd22 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd22 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  50. en:cd276 antigen positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd276 antigen positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  51. en:cd28 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd28 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  52. en:cd3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  53. en:cd30 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd30 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  54. en:cd33 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd33 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  55. en:cd34 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd34 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  56. en:cd4 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd4 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  57. en:cd44 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd44 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  58. en:cd5 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd5 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  59. en:cd52 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd52 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  60. en:cd57 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd57 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  61. en:cd7 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd7 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  62. en:cd70 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd70 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  63. en:cd79b positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd79b positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  64. en:cd8 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd8 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  65. en:cd86 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cd86 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  66. en:cdh3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cdh3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  67. en:cdkn2a-p16 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cdkn2a-p16 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  68. en:chromogranin positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:chromogranin positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  69. en:circulating tumor cells positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:circulating tumor cells positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  70. en:cldn18.2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cldn18.2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  71. en:clostridium difficile positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:clostridium difficile positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  72. en:clostridium difficile toxin positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:clostridium difficile toxin positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  73. en:col6a3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:col6a3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  74. en:coombs test positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:coombs test positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  75. en:crlf2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:crlf2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  76. en:ctag1b positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ctag1b positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  77. en:ctag2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ctag2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  78. en:ctla4 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ctla4 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  79. en:ctnnb1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ctnnb1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  80. en:ctrp biomarker terminology --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ctrp biomarker terminology | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  81. en:ctrp disease terminology --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ctrp disease terminology | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  82. en:ctrp molecular genetic biomarker terminology --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ctrp molecular genetic biomarker terminology | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  83. en:ctrp terminology --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ctrp terminology | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  84. en:cytomegalovirus positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:cytomegalovirus positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  85. en:disseminated tumor cells positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:disseminated tumor cells positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  86. en:dll3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:dll3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  87. en:egfrviii positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:egfrviii positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  88. en:enpp3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:enpp3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  89. en:epor fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:epor fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  90. en:epstein-barr virus antibody positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:epstein-barr virus antibody positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  91. en:epstein-barr virus dna positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:epstein-barr virus dna positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  92. en:epstein-barr virus early rna positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:epstein-barr virus early rna positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  93. en:epstein-barr virus positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:epstein-barr virus positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  94. en:erbb3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:erbb3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  95. en:eso-1 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:eso-1 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  96. en:estrogen receptor and/or progesterone receptor positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:estrogen receptor and/or progesterone receptor positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  97. en:estrogen receptor positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:estrogen receptor positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  98. en:f3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:f3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  99. en:fcer2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:fcer2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  100. en:fgf family alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:fgf family alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  101. en:fgf19 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:fgf19 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  102. en:fgfr family alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:fgfr family alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  103. en:fgfr1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:fgfr1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  104. en:fgfr2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:fgfr2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  105. en:fgfr2iiib positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:fgfr2iiib positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  106. en:flt3 internal tandem duplication positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:flt3 internal tandem duplication positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  107. en:flt3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:flt3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  108. en:folate receptor family positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:folate receptor family positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  109. en:folh1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:folh1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  110. en:foxo1 fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:foxo1 fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  111. en:ganglioside gd2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ganglioside gd2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  112. en:gli1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:gli1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  113. en:gnrhr positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:gnrhr positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  114. en:gpc3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:gpc3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  115. en:gpnmb positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:gpnmb positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  116. en:gucy2c positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:gucy2c positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  117. en:ha-1(h) genotype positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ha-1(h) genotype positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  118. en:hepatitis b surface antibody positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hepatitis b surface antibody positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  119. en:hepatitis b virus core antibody positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hepatitis b virus core antibody positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  120. en:hepatitis b virus positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hepatitis b virus positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  121. en:hepatitis c virus positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hepatitis c virus positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  122. en:her2/neu positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:her2/neu positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  123. en:heregulin positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:heregulin positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  124. en:hif1a overexpression positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hif1a overexpression positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  125. en:hla class i histocompatibility antigen, a-0201 alpha chain positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla class i histocompatibility antigen, a-0201 alpha chain positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  126. en:hla phenotype positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla phenotype positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  127. en:hla-a*0201 ha-1 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-a*0201 ha-1 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  128. en:hla-a*26 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-a*26 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  129. en:hla-a1 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-a1 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  130. en:hla-a11 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-a11 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  131. en:hla-a2 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-a2 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  132. en:hla-a24 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-a24 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  133. en:hla-a3 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-a3 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  134. en:hla-a3/a11 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-a3/a11 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  135. en:hla-a31 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-a31 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  136. en:hla-b*1501 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-b*1501 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  137. en:hla-b*4601 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-b*4601 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  138. en:hla-b*5103 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-b*5103 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  139. en:hla-c*0404 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-c*0404 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  140. en:hla-cw*0702 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-cw*0702 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  141. en:hla-dp4 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-dp4 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  142. en:hla-dpb1*04 positive cells present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hla-dpb1*04 positive cells present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  143. en:hormone receptor/her2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hormone receptor/her2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  144. en:hoxa10 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hoxa10 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  145. en:hoxa9 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:hoxa9 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  146. en:htlv-1 antibody positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:htlv-1 antibody positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  147. en:htlv-1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:htlv-1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  148. en:human anti-chimeric antibody positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:human anti-chimeric antibody positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  149. en:human anti-mouse antibodies positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:human anti-mouse antibodies positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  150. en:human herpesvirus 1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:human herpesvirus 1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  151. en:human herpesvirus 6 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:human herpesvirus 6 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  152. en:human herpesvirus 8 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:human herpesvirus 8 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  153. en:human immunodeficiency virus positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:human immunodeficiency virus positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  154. en:human papillomavirus positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:human papillomavirus positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  155. en:igf1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:igf1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  156. en:igf1r positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:igf1r positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  157. en:ighv4-34 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ighv4-34 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  158. en:il13ra2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:il13ra2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  159. en:il2ra positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:il2ra positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  160. en:il2rb positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:il2rb positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  161. en:interleukin-3 receptor subunit alpha positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:interleukin-3 receptor subunit alpha positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  162. en:irak1 fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:irak1 fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  163. en:isg15 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:isg15 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  164. en:jak2 fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:jak2 fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  165. en:jak3 fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:jak3 fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  166. en:jc virus positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:jc virus positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  167. en:kdr positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:kdr positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  168. en:kir2dl1 polymorphism positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:kir2dl1 polymorphism positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  169. en:kit overexpression positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:kit overexpression positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  170. en:kit positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:kit positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  171. en:kras positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:kras positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  172. en:latent membrane protein 1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:latent membrane protein 1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  173. en:lypd3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:lypd3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  174. en:magea10 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:magea10 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  175. en:magea12 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:magea12 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  176. en:magea3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:magea3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  177. en:magea4 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:magea4 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  178. en:magea6 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:magea6 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  179. en:magec1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:magec1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  180. en:mapk gene alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:mapk gene alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  181. en:mecom positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:mecom positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  182. en:merkel cell polyomavirus t antigen positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:merkel cell polyomavirus t antigen positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  183. en:mesothelin positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:mesothelin positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  184. en:met fusion gene positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:met fusion gene positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  185. en:met overexpression positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:met overexpression positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  186. en:met positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:met positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  187. en:mitf positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:mitf positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  188. en:mki67 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:mki67 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  189. en:mlana positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:mlana positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  190. en:mll positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:mll positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  191. en:monoclonal cellular population present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:monoclonal cellular population present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  192. en:mpo positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:mpo positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  193. en:muc1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:muc1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  194. en:muc16 ectodomain antigen positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:muc16 ectodomain antigen positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  195. en:muc16 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:muc16 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  196. en:myc positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:myc positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  197. en:mycn positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:mycn positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  198. en:myd88 fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:myd88 fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  199. en:ncam1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ncam1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  200. en:nectin4 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:nectin4 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  201. en:nf1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:nf1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  202. en:nos2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:nos2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  203. en:nr3c1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:nr3c1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  204. en:pdgfa gene fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:pdgfa gene fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  205. en:pdgfb gene fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:pdgfb gene fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  206. en:pdgfr positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:pdgfr positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  207. en:pdgfra gene fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:pdgfra gene fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  208. en:pdgfrb gene fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:pdgfrb gene fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  209. en:phosphorylated signal transducer and activator of transcription 3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:phosphorylated signal transducer and activator of transcription 3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  210. en:pi3k alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:pi3k alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  211. en:pmel positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:pmel positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  212. en:pml/rara fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:pml/rara fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  213. en:positive blood culture --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:positive blood culture | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  214. en:positive herpes simplex virus culture --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:positive herpes simplex virus culture | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  215. en:positive lymph node --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:positive lymph node | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  216. en:positive pseudomonas culture --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:positive pseudomonas culture | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  217. en:positive surgical margin --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:positive surgical margin | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  218. en:prame positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:prame positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  219. en:prlr positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:prlr positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  220. en:progesterone receptor positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:progesterone receptor positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  221. en:pten alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:pten alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  222. en:pten positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:pten positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  223. en:ptprc positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ptprc positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  224. en:pttg1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:pttg1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  225. en:rara positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:rara positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  226. en:rb1 gene alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:rb1 gene alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  227. en:rb1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:rb1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  228. en:rela fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:rela fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  229. en:ret fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ret fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  230. en:ret positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ret positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  231. en:ropn1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ropn1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  232. en:ror1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ror1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  233. en:ros1 fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ros1 fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  234. en:ros1 gene alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ros1 gene alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  235. en:ros1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ros1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  236. en:rous sarcoma virus positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:rous sarcoma virus positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  237. en:rspo gene fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:rspo gene fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  238. en:runx1/runx1t1 fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:runx1/runx1t1 fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  239. en:s100b positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:s100b positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  240. en:scgb2a2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:scgb2a2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  241. en:shh positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:shh positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  242. en:slc39a6 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:slc39a6 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  243. en:slc45a2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:slc45a2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  244. en:slc5a5 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:slc5a5 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  245. en:slc6a8 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:slc6a8 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  246. en:slco1b3 gene positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:slco1b3 gene positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  247. en:smarcb1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:smarcb1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  248. en:somatostatin receptor positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:somatostatin receptor positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  249. en:spa17 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:spa17 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  250. en:spanxb1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:spanxb1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  251. en:spn positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:spn positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  252. en:ssx2 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ssx2 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  253. en:steap1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:steap1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  254. en:survivin positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:survivin positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  255. en:t(11;14) positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:t(11;14) positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  256. en:t(15;17) positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:t(15;17) positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  257. en:tfe3 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:tfe3 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  258. en:thbs1 overexpression positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:thbs1 overexpression positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  259. en:tnfrsf17 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:tnfrsf17 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  260. en:tp53 gene alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:tp53 gene alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  261. en:tp53 overexpression positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:tp53 overexpression positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  262. en:tp53 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:tp53 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  263. en:trk receptor family alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:trk receptor family alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  264. en:tumor-associated peptide antigens present --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:tumor-associated peptide antigens present | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  265. en:tyk2 fusion positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:tyk2 fusion positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  266. en:tyrosinase positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:tyrosinase positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  267. en:ugt1a1 polymorphism positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:ugt1a1 polymorphism positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  268. en:vegf overexpression positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:vegf overexpression positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  269. en:wnt family gene alteration positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:wnt family gene alteration positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  270. en:wnt positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:wnt positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  271. en:wt1 positive --- r_associated #0: 20 --> en:ccnd2 positive
    n1=en:wt1 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  272. récepteur des androgènes positif --- r_associated #0: 10 --> en:ccnd2 positive
    n1=récepteur des androgènes positif | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=10
  273. présence d'antigènes peptidiques associés à la tumeur --- r_associated #0: 5 --> en:ccnd2 positive
    n1=présence d'antigènes peptidiques associés à la tumeur | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr